1 / 7

Overview

Overview. Haixi Pharmaceuticals was founded in Fuzhou, with great financial support of Fujian Province. Government-backed VCs are investing ￥ 30m for the initial startup fund, and local governments are committing additionally ￥ 15m each year for the first 3 years as research fund.

banyan
Télécharger la présentation

Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Overview Haixi Pharmaceuticals was founded in Fuzhou, with great financial support of Fujian Province. Government-backed VCs are investing ￥30m for the initial startup fund, and local governments are committing additionally ￥15m each year for the first 3 years as research fund. The goal is to become one of the best innovative drug companies in China and to set an excellent example for more companies in the industry to come to Fujian in the future.

  2. Current Team 康心汕，总裁，普林斯顿大学化学博士 1993年科大毕业，1999年获得普林斯顿大学的化学博士学位，加州大学旧金山分校的药学院和分子设计研究院博士后，在多家美国制药公司从事新药的设计和研发工作。2008年回国，先后担任浙江贝达药业的首席药学家，和北京贝美拓新药研发有限公司总经理。2012年6月创办福建海西新药创制有限公司。 吴其威，副总裁，加拿大西蒙菲沙大学分子生物学博士，美国斯坦福大学免疫学博士后 15年的生技药品研发及生产经验涉及抗体工程，蛋白质工程， 重组基因克隆和高效细胞株筛选，药品效能及安全性评估。先后在多家生物工司中担任技术总监。现负责启动和领导公司的人重组单克隆抗体药物项目及其产品线的建立。 刘日廷，副总裁，德州大学/安德森癌症中心生化博士，普渡大学工商管理硕士 1989年广州医学院/中山医科大学医学硕士，后在西安杨森制药公司担任销售经理, 是中国第一批外资企业的销售经理。美国德州大学/安德森癌症中心生化博士，普渡大学MBA（获最高额MBA奖学金）。回国后2006年出任上海复星医药集团商务发展总监，近20年在国际医药工业/生物技术领域著名跨国公司与研究机构的工作经验，曾组织团队完成约十项国际新药/技术引进。完成了多个新药立项研究，并领导所引进新药的临床前研究，临床实验和新药注册。

  3. Short-term Strategy 1, In two years, build a research pipeline of 6-10 Class I drug projects; 2, In two years, in-license one to two imported drug projects; 3, In two years, initiate or in-license a few Class III or unique Class VI drug projects; 4, In 3 years, form one to two project collaborations with renowned universities or pharma worldwide; 5, In 3 years, form collaborations with drug manufacturers in Fujian

  4. Entrepreneur Opportunity • Heads in Medicinal Chemistry/Process Chemistry, Biology/Pharmacology • Recruitment and buildup of their own teams; • Help in design & remodeling of their own labs; • Leading & management for drug research projects; • Initiating their own drug projects. • Project Consultants/Partners/Collaborators • Payment & Benefit: • Salary comparable to US • Stock Option/Shares in all company projects • Major shares in projects initiated by self • Standard benefit package for employees • Extra benefit package for returnees

  5. Thank You Please Contact: Jason X. Kang, CEO jason_xkang@hxpharma.com +86-186-5917-9368

More Related